Efficacy and Safety of a Biosimilar Versus Branded Enoxaparin in the Prevention of Venous Thromboembolism Following Major Abdominal Surgery: A Randomized, Prospective, Single-Blinded, Multicenter Clinical Trial

Several biosimilar versions of enoxaparin are already approved and in use globally. Analytical characterization can establish good quality control in manufacturing, but they may not assure similarity in clinical outcomes between biosimilar and branded enoxaparin. This study evaluated the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramacciotti, Eduardo, Ferreira, Ubirajara, Costa, Agenor José Vasconcelos, Raymundo, Selma Regina O., Correa, João Antônio, Neto, Salvador Gullo, Osvaldt, Alessandro Bersch, Agati, Leandro, Aguiar, Valéria Cristina Resende, Davila, Ronaldo, Caltabiano, Tania Benevenuto, Magella, Flávia Magalhães, Volpiani, Giuliano Giova, Castelli, Valter, Caffaro, Roberto Augusto, DalAcqua, Lucas Zeponi, Matheus, Wagner Eduardo, Sato, Debora Yuri, Russeff, Gleison Juliano da Silva, de Souza, Daniela Garcia, Pazetto, Lucas Eduardo, de Lima, Tiago Aparecido Maschio, Colnago, Eloá Maria da Silva, Fugii, Eliane Yumii, Mussalem, Juliana Sekeres, Assao, Vanessa Therumi, Toffoletto, Odaly, Rodrigues, Debora Garcia, Afiune, Jorge Barros, Araujo, Gilson Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714771/
https://www.ncbi.nlm.nih.gov/pubmed/30021463
http://dx.doi.org/10.1177/1076029618786583

Ejemplares similares

Ejemplares similares